8.7
Excellent
376 reviews
- Communication
- 8.8
- Timeliness
- 8.9
- Accuracy
- 7.6
- Staff
- 8.8
- Value
- 8.9
Jaime Glover V
8.8
- - Biostatistical Design
- - 4 weeks May - June 2023
- - Research Institution
Reviewed:
Excellent biostatistical support, clear and actionable insights.
The biostatistical support provided was top-notch, offering clear and actionable insights that were critical to the success of our study. The team was responsive and worked closely with us to ensure the analysis met our specific needs.
Krystal Franey
9.2
- - Regulatory Strategy Consulting
- - 4 weeks July - August 2024
- - Biotech Startup
Reviewed:
Thorough and strategic regulatory strategy consulting.
The regulatory strategy consulting services were thorough and provided us with a clear pathway to regulatory approval. The team's deep understanding of the regulatory landscape was invaluable, and their strategic advice was spot on.
Mathew Stehr
8.7
- - Patient Recruitment
- - 8 weeks March - April 2023
- - Clinical Research Organization
Reviewed:
Highly effective patient recruitment strategies, project completed on time.
The patient recruitment strategies were highly effective, and the project was completed within the agreed timeframe. The team was very professional, and their expertise in patient engagement was evident throughout.
Natasha Roberts
9.5
- - Gene Therapy Development
- - 12 weeks January - March 2023
- - Research Institution
Reviewed:
Innovative approach to gene therapy development, collaborative team.
The gene therapy project was managed exceptionally well, with innovative solutions provided at every stage. The team was highly collaborative and receptive to feedback, making it a truly joint effort. The results exceeded expectations.
Lana Pollich PhD
9
- - Biomarker Development
- - 12 weeks October 2023 - January 2024
- - Research Institution
Reviewed:
Efficient and precise biomarker development.
The biomarker development project was managed efficiently, with precise results that met our project objectives. The team's expertise in biomarker research was invaluable, and we were impressed with the quality of the deliverables.
Luke Kozey
8.9
- - Medical Writing
- - 5 weeks October - November 2023
- - Biotech Company
Reviewed:
Top-quality medical writing, clear and precise documents.
The medical writing services provided were of top quality. The documents were clear, precise, and tailored to meet the specific requirements of our regulatory submissions. The team's expertise was evident throughout the process.
Sadie Fisher
5.8
- - Biostatistical Design
- - 6 weeks February - March 2024
- - Research Institution
Reviewed:
Biostatistical analysis lacked depth, missed key insights.
The biostatistical analysis provided was not as thorough as we had hoped. Some key insights were missed, and we had to engage another provider to get the level of detail we needed. The team seemed overworked and under-resourced.
May Towne Jr.
9.1
- - Pharmacovigilance Services
- - Ongoing
- - Pharmaceutical Company
Reviewed:
Highly effective pharmacovigilance services, ensured compliance.
The pharmacovigilance services ensured that our post-market surveillance was compliant and effective. The team was proactive in monitoring and reporting, providing us with peace of mind and ensuring patient safety.
Terrance King
5.7
- - Project Management
- - 12 weeks March - May 2024
- - Biotech Company
Reviewed:
Poor communication and missed deadlines caused frustration.
Communication from the project management team was poor, with frequent missed deadlines. This caused significant frustration on our end, as we had to repeatedly chase them for updates. The project eventually got back on track, but the delays were problematic.